DUBLIN–(BUSINESS WIRE)–The “Colorectal Cancer Screening Tests Market Analysis by Screening Test (Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography, Colonoscopy), by End User (Independent Diagnostic Labs, Hospitals), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global colorectal cancer screening tests market size is estimated to be USD 12,994 million in 2021 and is expected to witness a CAGR of 7.76% during the forecast period.
Introduction of effective genetic tests is a key driver for the growth of the global colorectal cancer screening tests market. Additionally, increasing global cases of colorectal cancer and growth in cancer prevention initiatives in the colorectal cancer screening tests market are some of the other drivers propelling the market growth.
Nevertheless, insufficient healthcare access in developing economies and lack of knowledge regarding colorectal cancer screening tests among developing economies are expected to restrain the global market growth.
Companies Mentioned
- Abbott Laboratories (U.S.)
- Clinical Genomics Pty Ltd (U.S.)
- Epigenomics Inc. (Germany)
- EXACT Sciences Corporation (U.S.)
- F. Hoffmann-La Roche AG (Switzerland)
- Hemosure Inc. (U.S.)
- Novigenix SA (Switzerland)
- Quidel Corporation (U.S.)
- Siemens Healthineers AG (Germany)
- Sysmex Corporation (Japan)
Key Topics Covered:
1. Research Methodology
2. Introduction: Colorectal Cancer Screening Tests
3. Executive Summary
3.1. Global Market Scenario
3.2. Segment Market Scenario
3.3. Geographic Market Scenario
3.4. COVID-19 Impact
3.5. Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraint
4.3. Market Opportunities
4.4. Market Trends
4.5. Market Challenges
5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark
6. COVID-19 Impact Analysis: Colorectal Cancer Screening Tests Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets
7. Market Analysis by Screening Test
7.1. Flexible Sigmoidoscopy
7.1.1. Flexible Sigmoidoscopy Market Forecast, 2021-2029 (USD Million)
7.2. Stool-based Tests
7.2.1. Stool-based Tests Market Forecast, 2021-2029 (USD Million)
7.3. CT Colonography (Virtual Colonoscopy)
7.3.1. CT Colonography (Virtual Colonoscopy) Market Forecast, 2021-2029 (USD Million)
7.4. Colonoscopy
7.4.1. Colonoscopy Market Forecast, 2021-2029 (USD Million)
7.5. Others
7.5.1. Others Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by End User
8.1. Independent Diagnostic Labs
8.1.1. Independent Diagnostic Labs Market Forecast, 2021-2029 (USD Million)
8.2. Hospitals
8.2.1. Hospitals Market Forecast, 2021-2029 (USD Million)
8.3. Others
8.3.1. Others Market Forecast, 2021-2029 (USD Million)
9. Regional Market Analysis
9.1. Regional Market Trends
9.2. Regional Market: Comparative Analysis
10. North America Colorectal Cancer Screening Tests Market
11. Europe Colorectal Cancer Screening Tests Market
12. Asia Pacific Colorectal Cancer Screening Tests Market
13. Latin America Colorectal Cancer Screening Tests Market
14. MEA Colorectal Cancer Screening Tests Market
15. Competitor Analysis
15.1. Market Share Analysis, 2021 & 2029
15.2. Competitive Mapping
15.3. Key Players Market Place Analysis
15.4. Major Recent Developments
16. Company Profiles
17. Conclusion & Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/ybblo8
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
